P300 and the Stroop Effect in Overweight Minority Adolescents

被引:13
|
作者
Bauer, Lance O. [1 ]
Kaplan, Richard F. [1 ]
Hesselbrock, Victor M. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Psychiat, Sch Med, Farmington, CT 06030 USA
关键词
P300; Evoked potentials; Overweight; Family history; Externalizing disorders; Obesity; Adolescents; Stroop effect; BODY-MASS INDEX; ANTERIOR CINGULATE CORTEX; FAMILY-HISTORY; EXECUTIVE DYSFUNCTION; COGNITIVE FUNCTION; OBESE WOMEN; ALCOHOL; HYPERTENSION; IMPULSIVITY; CONFLICT;
D O I
10.1159/000297735
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aim: The goal was to examine the relationship between a risk factor for poor cognitive control and a health outcome of growing public significance - an excess body mass among adolescents. Methods: To this end, 109 adolescents aged 14-20 years were recruited and assigned to 1 of 4 groups defined by the crossing of the absence versus presence of a parental history (PH) of externalizing disorders with a body mass index (BMI) percentile (BMIP) <85 versus >= 85. The principal measure estimating cognitive control was the P300 event-related electroencephalographic response recorded during the Stroop task. Results: The analyses revealed a synergistic interaction between BMIP rank, PH and trial type: the increase in P300 latency and the decrease in response accuracy, elicited by the presence of interfering information, were markedly greater in high-BMIP subjects with a PH of externalizing disorders than in the other subject groups. Analyses of a later component, the N450, previously associated with the Stroop interference effect, revealed no effect of BMI or PH. Conclusions: We conclude that subjects with both a PH of externalizing disorders and an excess BMI constitute a unique group that is less able to resolve cognitive conflict than others. The excessive delay in P300 evoked by conflicting response demands in these subjects may be a marker of a heritable factor that increases risk for both excess body mass and substance use disorders. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:180 / 187
页数:8
相关论文
共 50 条
  • [31] EFFECT OF FENTANYL AND NALOXONE ON THE P300 AUDITORY POTENTIAL
    VELASCO, M
    VELASCO, F
    CASTANEDA, R
    LEE, M
    NEUROPHARMACOLOGY, 1984, 23 (08) : 931 - 938
  • [32] Emotional valence effect on P300: a topographical approach
    Delplanque, S
    Hot, P
    Lavoie, M
    Sequeira, H
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2001, 41 (03) : 231 - 231
  • [33] The effect of video distraction on a visual P300 BCI
    Kim, Minju
    Choi, Yun Joo
    Kim, Jongsu
    Kim, Sung-Phil
    2021 9TH IEEE INTERNATIONAL WINTER CONFERENCE ON BRAIN-COMPUTER INTERFACE (BCI), 2021, : 147 - 151
  • [34] The effect of the skull on event-related P300
    Frodl, T
    Meisenzahl, EM
    Müller, D
    Leinsinger, G
    Juckel, G
    Hahn, K
    Möller, HJ
    Hegerl, U
    CLINICAL NEUROPHYSIOLOGY, 2001, 112 (09) : 1773 - 1776
  • [35] THE EFFECT OF PRESTIMULUS ALPHA-ACTIVITY ON THE P300
    JASIUKAITIS, P
    HAKEREM, G
    PSYCHOPHYSIOLOGY, 1988, 25 (02) : 157 - 165
  • [36] P300 IN HEAVY SOCIAL DRINKERS - THE EFFECT OF LORAZEPAM
    NICHOLS, JM
    MARTIN, F
    ALCOHOL, 1993, 10 (04) : 269 - 274
  • [37] THE P300 BCI IS MORE THAN AN ODDBALL AND MORE THAN A P300 BCI
    Shishkin, Sergei L.
    Ganin, Ilya P.
    Kaplan, Alexander Ya
    PSYCHOPHYSIOLOGY, 2009, 46 : S47 - S47
  • [38] Hypothesis on the P300 generators based on visual P300 results in neurological disorders
    Kuroiwa, Y
    Wang, LH
    Kamitani, T
    Yamazaki, T
    Kenmochi, A
    Kamijo, K
    BRAIN TOPOGRAPHY TODAY, 1997, 1147 : 354 - 357
  • [39] CATECHOLAMINERGIC FUNCTION AND P300 AMPLITUDE IN MAJOR DEPRESSIVE DISORDER (P300 AND CATECHOLAMINES)
    HANSENNE, M
    PITCHOT, W
    MORENO, AG
    PAPART, P
    TIMSITBERTHIER, M
    ANSSEAU, M
    EVOKED POTENTIALS-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1995, 96 (02): : 194 - 196
  • [40] P300 evidence of cognitive inflexibility in female adolescents at risk for recurrent depression
    Houston, RJ
    Bauer, LO
    Hesselbrook, VM
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (03): : 529 - 536